Norazide (Hydrochlorothiazide, Ramipril)

Hydrochlorothiazide increases the excretion of sodium and water by inhibiting NaCl reabsorption in the distal convoluted tubule, reducing plasma volume. Ramipril blocks the conversion of angiotensin I to angiotensin II, decreasing vasoconstriction and aldosterone release. Together they provide complementary mechanisms that lower systemic vascular resistance and blood pressure.

The appropriate dose of Norazide is determined by the prescribing clinician based on the patient’s medical condition, response to therapy, and any concomitant medications. Dosage adjustments may be required for renal function, age, or electrolyte status, and the prescriber will provide specific instructions.

The safety of Norazide in pregnancy and lactation has not been established. ACE inhibitors such as ramipril are generally contraindicated in the second and third trimesters because of fetal toxicity. Women who are pregnant, planning pregnancy, or breastfeeding should discuss alternative treatments with their healthcare provider.

To request Norazide, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements), and the necessary import documentation.

Norazide offers a fixed‑dose combination of a thiazide diuretic and an ACE inhibitor, which can simplify regimens and improve adherence compared with taking two separate tablets. Compared with monotherapy, the combination often achieves greater blood‑pressure reduction, but individual patient factors and tolerance determine the most appropriate therapy.

Norazide tablets should be stored at ambient temperature, below 25 °C, in the original container to protect them from moisture and light. Keep the product out of reach of children and do not use if the packaging is damaged.

Norazide is taken orally, usually once daily, with or without food as directed by the prescriber. Swallow the tablet whole with a full glass of water and follow any specific timing instructions provided by the healthcare professional.

The most serious risks include angioedema (swelling of the face, lips, tongue, or airway), severe hypotension especially after the first dose, and acute renal impairment manifested by a rapid rise in serum creatinine. Patients should seek immediate medical attention if they experience any of these symptoms.

Norazide should be avoided in patients with known hypersensitivity to either hydrochlorothiazide or ramipril, those with a history of angioedema related to ACE inhibitors, severe renal impairment, or significant electrolyte disturbances. It is also contraindicated in pregnancy, particularly in the second and third trimesters.